세계의 아드세트리스(Adcetris) 시장 보고서(2025년) : 역학, 파이프라인 분석, 시장 인사이트 및 예측

Adcetris Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

US $ 4,490 ￦ 6,430,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,294,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,159,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

아드세트리스 시장 규모는 향후 몇 년간 강한 성장을 기록할 것으로 예상됩니다. 예측 기간 동안의 성장은 암 연구에 대한 투자 증가, 정밀 의학에 대한 수요 증가, 신흥 시장 진출 확대, 환자 접근 프로그램에 대한 집중 강화, 확장된 적응증에 대한 임상 시험 진행 등이 주요 요인으로 작용할 것입니다. 예측 기간의 주요 트렌드로는 종양학에서 표적 치료의 채택 증가, CD30 양성 악성 종양에 대한 새로운 적응증으로의 확장, 신흥 시장의 의료비 지출 및 접근성 증가, 항체-약물 복합체 기술의 발전, 개인 맞춤형 암 치료에 대한 수요 증가 등이 있습니다.

암의 유병률이 증가함에 따라 향후 몇 년 동안 아드세트리스 시장의 성장이 촉진될 것으로 예상됩니다. 암은 신체 내에서 비정상적인 세포가 통제되지 않고 증식하고 확산되는 것을 특징으로 하는 질병의 집합체입니다. 암 발병률의 증가는 주로 식습관 및 신체 활동 부족과 같은 생활 습관 요인, 환경 오염 물질에 대한 노출 증가, 진단 방법의 발전에 기인합니다. 아드세트리스는 CD30 양성 암세포를 특이적으로 표적화하고 결합하여 강력한 세포 독성 물질을 종양에 직접 전달함으로써 암 환자에게 상당한 이점을 제공합니다. 또한 치료 효과를 개선하고 전신 부작용을 최소화하며 특정 유형의 호지킨 림프종 및 기타 CD30 발현 암 환자에게 유망한 치료 옵션을 제공합니다. 예를 들어, 2023년 1월 미국 암 학회(American Cancer Society)는 미국 내 암 발병 건수가 195만 8,310명에 이르고, 암 관련 사망이 60만 9,820명에 달했다고 보고했습니다.

아드세트리스 시장의 두드러진 동향은 강화된 항체-약물 복합체(ADC) 및 조합 요법을 포함한 개선된 약물 전달 시스템의 개발에 초점을 두고 있습니다. 이러한 전략은 치료 효능을 개선하고, 부작용을 최소화하며, 암세포를 보다 정확하게 표적화하기 위한 것입니다. 조합 요법은 두 가지 이상의 작용 기전을 가진 치료제를, 종종 시너지 효과를 발휘하도록 함께 사용하여 효능을 높이고, 내성을 감소시키며, 환자의 치료 결과를 개선하는 동시에 단일 요법에 비해 부작용을 잠재적으로 감소시키는 것입니다. 예를 들어, 2023년 10월 다케다 제약은 유럽 의약품청(EC)으로부터 아드세트리스(브렌투시맙 베도틴)를 도ксо루비신, 빈블라스틴, 다카르바진(AVD)과 조합해 이전에 치료받지 않은 CD30+ 3기 호지킨 림프종 성인 환자의 치료에 사용하도록 승인을 받았습니다. 이 ADC는 호지킨 림프종의 주요 표지자인 CD30를 표적합니다. 임상 시험 결과, 아드세트리스를 AVD와 병용 투여한 경우 표준 치료에 비해 수정된 무진행 생존율과 전체 생존율이 유의미하게 개선되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 바이오의약품 시장에서의 제품 특성

• 분자 유형
• 투여 경로(ROA)
• 작용 기전(MOA)
• 안전성과 유효성

제4장 시장 동향과 전략

제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제6장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 아드세트리스 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 아드세트리스 시장 : 성장률 분석
• 세계의 아드세트리스 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 아드세트리스 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 아드세트리스 : 전체 시장 규모(TAM)

제7장 세계 시장의 가격 분석과 예측

제8장 시장 세분화

• 세계의 아드세트리스 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 분말
• 액체
• 세계의 아드세트리스 시장 : 적응증별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 호지킨 림프종
• 전신성 미분화 대세포 림프종
• 피부 T세포 림프종
• 기타
• 세계의 아드세트리스 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 약국
• 기타

제9장 임상적응증 세계 시장 역학

• 약제의 부작용
• 임상적응증의 발병률과 유병률

제10장 지역별, 국가별 분석

• 세계의 아드세트리스 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 아드세트리스 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 한국 시장

제17장 서유럽 시장

제18장 영국 시장

제19장 독일 시장

제20장 프랑스 시장

제21장 동유럽 시장

제22장 북미 시장

제23장 미국 시장

제24장 캐나다 시장

제25장 남미 시장

제26장 중동 시장

제27장 아프리카 시장

제28장 경쟁 구도와 기업 프로파일

• 아드세트리스 시장 : 경쟁 구도
• 아드세트리스 시장 : 기업 프로파일
  • Takeda Pharmaceutical Company Limited
  • Seagen Inc.

제29장 세계 시장 : 파이프라인 분석

제30장 세계 시장 경쟁 벤치마킹과 대시보드

제31장 주요 인수합병(M&A)

제32장 최근 시장 동향

제33장 시장의 잠재력이 높은 국가, 전략

• 아드세트리스 시장(2029년) : 새로운 기회를 제공하는 국가
• 아드세트리스 시장(2029년) : 새로운 기회를 제공하는 부문
• 아드세트리스 시장(2029년) : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제34장 부록

HBR

영문 목차

영문목차

Adcetris (brentuximab vedotin) is an antibody-drug conjugate (ADC) designed to target CD30, a protein present on the surface of certain cancer cells, including those associated with Hodgkin lymphoma and systemic anaplastic large cell lymphoma. It combines a monoclonal antibody with a cytotoxic agent, monomethyl auristatin E (MMAE), enabling targeted chemotherapy delivery to cancer cells, enhancing efficacy while minimizing off-target side effects.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary forms of adcetris are powder and liquid. It is provided as a sterile, white to off-white lyophilized powder in single-dose vials. Before administration, healthcare providers reconstitute the powder with a specified amount of sterile water to prepare it for intravenous infusion. Its indications include Hodgkin lymphoma, systemic anaplastic large-cell lymphoma, cutaneous T-cell lymphoma, and others. Adcetris is utilized in various settings, such as hospitals, drug stores, and more.

The adcetris market research report is one of a series of new reports from The Business Research Company that provides adcetris market statistics, including adcetris industry global market size, regional shares, competitors with a adcetris market share, detailed adcetris market segments, market trends, and opportunities, and any further data you may need to thrive in the adcetris industry. This adcetris market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adcetris market size is expected to see strong growth in the next few years. It will grow to $1,954.7 million in 2029 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to rising investment in oncology research, increasing demand for precision medicine, expansion into emerging markets, growing focus on patient access programs, ongoing clinical trials for expanded indications. Major trends in the forecast period include increasing adoption of targeted therapies in oncology, expansion into new indications for CD30-positive malignancies, growth in healthcare spending and access in emerging markets, advancements in antibody-drug conjugate technologies, increasing demand for personalized cancer treatments.

The increasing prevalence of cancer is projected to drive the growth of the adcetris market in the coming years. Cancer is a collection of diseases characterized by the uncontrolled growth and spread of abnormal cells within the body. The rise in cancer cases is largely attributed to lifestyle factors, such as poor diet and physical inactivity, increased exposure to environmental pollutants, and advancements in diagnostic methods. Adcetris provides substantial benefits for cancer patients by specifically targeting and binding to CD30-positive cancer cells, delivering potent cytotoxic agents directly to the tumor, improving treatment effectiveness, minimizing systemic side effects, and presenting a promising treatment option for patients with certain types of Hodgkin lymphoma and other CD30-expressing cancers. For example, in January 2023, the American Cancer Society reported that the number of cancer cases in the United States reached 1,958,310, with 609,820 cancer-related deaths. As a result, the growing incidence of cancer is a key factor driving the adcetris market.

A prominent trend in the adcetris market is the focus on developing enhanced antibody-drug conjugates (ADCs) and improved drug delivery systems, including combination therapies. These strategies aim to improve therapeutic efficacy, minimize side effects, and more precisely target cancer cells. Combination therapies involve using two or more therapeutic agents with different mechanisms of action, often in synergy, to boost efficacy, reduce resistance, and enhance patient outcomes, while potentially lowering adverse effects compared to monotherapy. For instance, in October 2023, Takeda Pharmaceutical Company received approval from the European Commission (EC) for the use of ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine, and dacarbazine (AVD) for treating adults with previously untreated CD30+ Stage III Hodgkin lymphoma. This ADC targets CD30, a key marker in Hodgkin lymphoma. The trial results showed that combining ADCETRIS with AVD significantly improved both modified progression-free survival and overall survival rates compared to standard treatments.

In January 2024, Pfizer Inc. acquired Seagen Inc. for $43 billion. This acquisition aims to strengthen Pfizer's oncology portfolio by incorporating Seagen's innovative ADCs, including Adcetris, to enhance its cancer treatment offerings. The move is designed to drive growth in targeted therapies and accelerate Pfizer's ability to deliver advanced cancer treatments to patients worldwide. Seagen Inc. is a US-based biotechnology firm that markets Adcetris.

Major players operating in the adcetris market are Takeda Pharmaceutical Company Limited; Seagen Inc.

North America was the largest region in the adcetris market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in adcetris report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the adcetris market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The adcetris market consists of sales of brentuximab vedotin-based therapies such as antibody-drug conjugates (ADCs), bispecific antibodies, and immune checkpoint inhibitors for the treatment of lymphoma and related cancers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Adcetris Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on adcetris market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for adcetris ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The adcetris market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Powder; Liquid
• 2) By Indication: Hodgkin Lymphoma; Systemic Anaplastic Large Cell Lymphoma; Cutaneous T-Cell Lymphoma; Other Indication
• 3) By Application: Hospital; Drugs Store; Other Applications
• Companies Mentioned: Takeda Pharmaceutical Company Limited; Seagen Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Adcetris Market Characteristics

3. Adcetris Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Adcetris Market Trends And Strategies

5. Adcetris Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Adcetris Growth Analysis And Strategic Analysis Framework

• 6.1. Global Adcetris PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Adcetris Market Growth Rate Analysis
• 6.4. Global Adcetris Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Adcetris Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Adcetris Total Addressable Market (TAM)

7. Global Adcetris Market Pricing Analysis & Forecasts

8. Adcetris Market Segmentation

• 8.1. Global Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Podwer
• Liquid
• 8.2. Global Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hodgkin Lymphoma
• Systemic Anaplastic Large Cell Lymphoma
• Cutaneous T-Cell Lymphoma
• Other Indication
• 8.3. Global Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Drugs Store
• Other Applications

9. Global Adcetris Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Adcetris Market Regional And Country Analysis

• 10.1. Global Adcetris Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Adcetris Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Adcetris Market

• 11.1. Asia-Pacific Adcetris Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Adcetris Market

• 12.1. China Adcetris Market Overview
• 12.2. China Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Adcetris Market

• 13.1. India Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Adcetris Market

• 14.1. Japan Adcetris Market Overview
• 14.2. Japan Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Adcetris Market

• 15.1. Australia Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Adcetris Market

• 16.1. South Korea Adcetris Market Overview
• 16.2. South Korea Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Adcetris Market

• 17.1. Western Europe Adcetris Market Overview
• 17.2. Western Europe Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Adcetris Market

• 18.1. UK Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Adcetris Market

• 19.1. Germany Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Adcetris Market

• 20.1. France Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Adcetris Market

• 21.1. Eastern Europe Adcetris Market Overview
• 21.2. Eastern Europe Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Adcetris Market

• 22.1. North America Adcetris Market Overview
• 22.2. North America Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Adcetris Market

• 23.1. USA Adcetris Market Overview
• 23.2. USA Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Adcetris Market

• 24.1. Canada Adcetris Market Overview
• 24.2. Canada Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Adcetris Market

• 25.1. South America Adcetris Market Overview
• 25.2. South America Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Adcetris Market

• 26.1. Middle East Adcetris Market Overview
• 26.2. Middle East Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Adcetris Market

• 27.1. Africa Adcetris Market Overview
• 27.2. Africa Adcetris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Adcetris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Adcetris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Adcetris Market Competitive Landscape And Company Profiles

• 28.1. Adcetris Market Competitive Landscape
• 28.2. Adcetris Market Company Profiles
  • 28.2.1. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.2. Seagen Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Adcetris Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Adcetris Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Adcetris Market

32. Recent Developments In The Adcetris Market

33. Adcetris Market High Potential Countries, Segments and Strategies

• 33.1 Adcetris Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Adcetris Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Adcetris Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer

관련자료